JP2020513050A5 - - Google Patents

Download PDF

Info

Publication number
JP2020513050A5
JP2020513050A5 JP2019553932A JP2019553932A JP2020513050A5 JP 2020513050 A5 JP2020513050 A5 JP 2020513050A5 JP 2019553932 A JP2019553932 A JP 2019553932A JP 2019553932 A JP2019553932 A JP 2019553932A JP 2020513050 A5 JP2020513050 A5 JP 2020513050A5
Authority
JP
Japan
Prior art keywords
compound according
item
composition
alkyl
quencher
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019553932A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020513050A (ja
JP7149614B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/025567 external-priority patent/WO2018183960A1/en
Publication of JP2020513050A publication Critical patent/JP2020513050A/ja
Publication of JP2020513050A5 publication Critical patent/JP2020513050A5/ja
Application granted granted Critical
Publication of JP7149614B2 publication Critical patent/JP7149614B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019553932A 2017-03-30 2018-03-30 in vivo画像化のためのプロテアーゼ活性化コントラスト剤 Active JP7149614B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762478639P 2017-03-30 2017-03-30
US62/478,639 2017-03-30
PCT/US2018/025567 WO2018183960A1 (en) 2017-03-30 2018-03-30 Protease-activated contrast agents for in vivo imaging

Publications (3)

Publication Number Publication Date
JP2020513050A JP2020513050A (ja) 2020-04-30
JP2020513050A5 true JP2020513050A5 (cg-RX-API-DMAC7.html) 2021-05-06
JP7149614B2 JP7149614B2 (ja) 2022-10-07

Family

ID=63678348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019553932A Active JP7149614B2 (ja) 2017-03-30 2018-03-30 in vivo画像化のためのプロテアーゼ活性化コントラスト剤

Country Status (6)

Country Link
US (2) US11828752B2 (cg-RX-API-DMAC7.html)
EP (1) EP3601261A4 (cg-RX-API-DMAC7.html)
JP (1) JP7149614B2 (cg-RX-API-DMAC7.html)
KR (1) KR102669535B1 (cg-RX-API-DMAC7.html)
CN (1) CN110678460A (cg-RX-API-DMAC7.html)
WO (1) WO2018183960A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107406872B (zh) * 2015-01-22 2023-03-28 里兰斯坦福初级大学理事会 用于标记动物组织的化合物、组合物及其应用
WO2022203930A1 (en) * 2021-03-24 2022-09-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Fluorogenic cyanine carbamates
CN116199675B (zh) * 2021-11-30 2024-08-20 中国科学院大连化学物理研究所 一类罗丹明荧光淬灭剂及其合成和应用
CN116199662B (zh) * 2021-11-30 2024-10-11 中国科学院大连化学物理研究所 一种可见光和近红外光罗丹明荧光淬灭剂及其合成和应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60888A (en) 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
US5055451A (en) 1986-12-22 1991-10-08 Syntex Inc. Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
WO1996041638A1 (en) 1995-06-13 1996-12-27 Sanofi Winthrop, Inc. Calpain inhibitors for the treatment of neurodegenerative diseases
US6544951B2 (en) 1998-07-02 2003-04-08 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
US20020052323A1 (en) 2000-08-30 2002-05-02 Jinhai Wang Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents
GB0112868D0 (en) * 2001-05-25 2001-07-18 Secr Defence Detection system
US7303741B2 (en) 2002-09-23 2007-12-04 General Electric Company Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism
JP2008522624A (ja) 2004-12-09 2008-07-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘミアスタリン(hemiasterlin)アナログを使用する癌治療におけるチューブリンのアイソタイプのスクリーニング
US8968700B2 (en) 2005-08-11 2015-03-03 The Board Of Trustees Of The Leland Stanford Junior University Imaging of protease activity in live cells using activity based probes
WO2008104271A2 (en) 2007-02-28 2008-09-04 Sanofi-Aventis Imaging probes
CN101652149B (zh) 2007-02-28 2012-11-14 塞诺菲-安万特股份有限公司 成像探针
MY148484A (en) 2007-08-03 2013-04-30 Sanofi Aventis Caspase imaging probes
US20090214436A1 (en) 2008-02-18 2009-08-27 Washington University Dichromic fluorescent compounds
US8343458B2 (en) 2008-04-03 2013-01-01 The Board Of Trustees Of The Leland Stanford Junior University Probes for in vivo targeting of active cysteine proteases
US9155471B2 (en) 2009-05-27 2015-10-13 Lumicell, Inc'. Methods and systems for spatially identifying abnormal cells
WO2012021800A2 (en) 2010-08-13 2012-02-16 Banyan Biomarkers Caspase inhibitors as therapeutics for neural and organ injury and imaging
US9180209B2 (en) 2011-02-28 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Non-peptidic quenched fluorescent imaging probes
WO2012129128A1 (en) 2011-03-18 2012-09-27 Biotium, Inc. Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules
US20140249468A1 (en) 2011-09-09 2014-09-04 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Imaging agents for imaging protease activity and uses thereof
US20140180073A1 (en) 2012-12-24 2014-06-26 Anticancer, Inc. Portable digital imaging system for fluorescence-guided surgery
WO2014152389A1 (en) 2013-03-14 2014-09-25 Lumicell, Inc. Imaging agent for detection of diseased cells
EP4218829A3 (en) * 2013-03-15 2023-08-16 The Board of Trustees of the Leland Stanford Junior University Activity-based probe compounds, compositions, and methods of use
SG11201508185YA (en) 2013-04-19 2015-11-27 Agency Science Tech & Res Tunable fluorescence using cleavable linkers
WO2015075699A1 (en) * 2013-11-25 2015-05-28 Sanofi Dotam derivatives for therapeutic use
CN107406872B (zh) * 2015-01-22 2023-03-28 里兰斯坦福初级大学理事会 用于标记动物组织的化合物、组合物及其应用
US10288388B1 (en) * 2015-12-28 2019-05-14 Taser International, Inc. Methods and apparatus for a cartridge used with a conducted electrical weapon

Similar Documents

Publication Publication Date Title
ES2385066T3 (es) Péptidos de unión a HGF marcados para la formación de imágenes
JP2018511556A5 (cg-RX-API-DMAC7.html)
ES2729555T3 (es) Inhibidores homomultivalentes y heteromultivalentes de antígeno de membrana específico de próstata (PMSA) y usos de los mismos
JP2016518341A5 (cg-RX-API-DMAC7.html)
ES2736134T3 (es) Derivado peptídico de tiourea, compuesto marcado con radioisótopos que contiene el mismo y composición farmacéutica que contiene el mismo como ingrediente activo para tratar o diagnosticar el cáncer de próstata
US10278965B2 (en) Method of detecting cancer stem cell, method of screening cancer stem cell, and method of inhibiting cancer stem cell
EP2849752B1 (en) Cancer cell inhibitory drug and cancer stem-cell detection probe
ES2476041T3 (es) Agente citoprotector trifenilfen�lico
JP2003500367A5 (cg-RX-API-DMAC7.html)
CN105431546A (zh) 基于活性的探针化合物、组合物及其使用方法
US20190321313A1 (en) Benzenesulfonamide derivatives and method for treating cancer
CA2911414A1 (en) Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
BR112020019367A2 (pt) formulação liofilizada, composição farmacêutica, conjunto para a preparação da composição farmacêutica, métodos de preparo de uma formulação liofilizada, de imageamento do corpo mamífero, de detecção, diagnóstico, cirurgia, estadiamento, tratamento, monitoramento de tratamento, monitoramento de progressão de doença ou terapia de monitoramento, de monitoramento de progressão de doença ou terapia de monitoramento de sítios de superexpressão ou localização de cmet, de obtenção de uma imagem de sítios de superexpressão ou localização de cmet, opcionalmente in vivo, e, uso
Murat Canger et al. Mandibular involvement of solitary plasmocytoma: a case report
JP2021525875A5 (cg-RX-API-DMAC7.html)
US20030088885A1 (en) Enhanced resolution of tumor metastasis using a skin flap model
ES2343674T3 (es) Farmacos preventivos o curativos para el endometriosis.
Fonseca et al. Ostomy metastasis after pull endoscopic gastrostomy: a unique favorable outcome
JP2020513050A (ja) in vivo画像化のためのプロテアーゼ活性化コントラスト剤
JP2004520365A5 (cg-RX-API-DMAC7.html)
Wada et al. Leiomyosarcoma in the maxilla: A case report
JP7847538B2 (ja) フルオロフォア標識upar標的化ペプチドコンジュゲートを含む組成物
ES2309222T3 (es) Inhibidores no nucleosidos de la transcriptasa inversa como antagonistas de la proliferacion celular e inductores de la diferenciacion celular.
US20220387632A1 (en) Renal clearable fluorescent contrast agent with increased tumor specificity, and imaging method using same
CN116917419B (zh) 用于肿瘤检测和外科手术指导的化合物和组合物